Your browser doesn't support javascript.
loading
An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.
Arab, Juan P; Sehrawat, Tejasav S; Simonetto, Douglas A; Verma, Vikas K; Feng, Dechun; Tang, Tom; Dreyer, Kevin; Yan, Xiaoqiang; Daley, William L; Sanyal, Arun; Chalasani, Naga; Radaeva, Svetlana; Yang, Liu; Vargas, Hugo; Ibacache, Mauricio; Gao, Bin; Gores, Gregory J; Malhi, Harmeet; Kamath, Patrick S; Shah, Vijay H.
Afiliação
  • Arab JP; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Sehrawat TS; Department of Gastroenterology, School of Medicine, Pontifical Catholic University of Chile, Santiago, Chile.
  • Simonetto DA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Verma VK; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Feng D; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Tang T; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD.
  • Dreyer K; Generon Corporation Ltd., Shanghai, China.
  • Yan X; Generon Corporation Ltd., Shanghai, China.
  • Daley WL; Generon Corporation Ltd., Shanghai, China.
  • Sanyal A; Generon Corporation Ltd., Shanghai, China.
  • Chalasani N; Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA.
  • Radaeva S; Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, IN.
  • Yang L; National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
  • Vargas H; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL.
  • Ibacache M; Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ.
  • Gao B; Division of Anesthesiology, School of Medicine, Pontifical Catholic University of Chile, Santiago, Chile.
  • Gores GJ; Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD.
  • Malhi H; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Kamath PS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Shah VH; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Hepatology ; 72(2): 441-453, 2020 08.
Article em En | MEDLINE | ID: mdl-31774566
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Proteínas Recombinantes de Fusão / Imunoglobulina G / Interleucinas / Hepatite Alcoólica Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Mongólia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Proteínas Recombinantes de Fusão / Imunoglobulina G / Interleucinas / Hepatite Alcoólica Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Mongólia